The antibody levels to SAR-CoV-2, the virus that causes COVID-19, substantially drop in the weeks following infection, according to a study led by Vanderbilt University Medical Center and the Centers for Disease Control and Prevention (CDC). In an April study of 19 health care workers at VUMC with detectable antibodies to SARS-CoV-2, 58% had antibody levels … Continued
In partnership with Assist International and Project ECHO, Vanderbilt University Medical Center and Vanderbilt Institute for Global Health are offering a tele-education series that will provide remote training and a platform for discussion and the sharing of best practices for healthcare providers caring for COVID patients in low-resource settings.
Six percent of health care personnel (HCP) caring for patients with COVID-19 have positive test results for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies, according to research published in the Aug. 31 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report. Wesley H. Self, M.D., from the … Continued
Vanderbilt University Medical Center has been awarded a one-year, $34-million grant by the National Center for Advancing Translational Sciences, part of the National Institutes of Health, to conduct a nationwide study of “convalescent plasma” as a treatment for COVID-19. The randomized, controlled trial will test whether infusions of plasma, the liquid part of blood collected from … Continued
In continued combat against COVID-19, the call for more and better data has grown gradually louder: good information to help equip researchers with understanding of the virus — and options to fight it. One of the treatments now considered among the more promising: convalescent plasma — shown as safe over decades of use, and widely touted … Continued
Vanderbilt University Medical Center is looking for up to 1,000 volunteers to participate in the late-stage trial of an experimental COVID-19 vaccine. The hospital says it will begin recruiting people at the end of the month. The vaccine is being developed by Moderna Inc. with the Vaccine Research Center of the National Institute of Allergy and … Continued
The study, called Human Epidemiology and Response to SARS-CoV-2 (HEROS), is funded by the National Institutes of Health and lead by Tina V. Hartert, M.D., M.P.H., director of the Center for Asthma and Environmental Sciences Research, vice president for translational research, the Lulu H. Owen Chair in Medicine and a professor of medicine at the … Continued
Lung disease experts at Vanderbilt University Medical Center and their colleagues have determined a key factor as to why COVID-19 appears to infect and sicken adults and older people preferentially while seeming to spare younger children. The researchers discovered that children have lower levels of an enzyme the virus needs to invade airway epithelial cells … Continued
Vanderbilt University Medical Center investigators are using imaging and diagnostic pathology to examine postmortem hearts donated by victims of COVID-19. They are looking for blood clots, vascular damage and inflammation to gain a better understanding of how the coronavirus that causes COVID-19 affects the heart.
Vanderbilt University Medical Center investigators have joined an international genetics effort to make advances as quickly as possible on understanding and treating COVID-19. The COVID-19 Host Genetics Initiative is bringing together the human genetics community to share resources for genetics research, such as consent forms, sample collection procedures and algorithms for utilizing data as it comes … Continued